Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (91-100 of 352) with videos related to

Pageof 36
Sort By:
World Journal of Gastroenterology|November 28, 2018
Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic reviewJulian Panes, Walter Reinisch, Ewa Rupniewska, et al.
Gut|November 7, 2022
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trialHeinz Zoller, Myles Wolf, Irina Blumenstein, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates|October 2, 2018
A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient GroupsJeremy Yongwen Ng, Usha Chauhan, David Armstrong, et al.
Crohn'S & Colitis 360|February 13, 2023
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative AnalysisDavid T Rubin, Laurent Peyrin-Biroulet, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2021
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative ColitisNeeraj Narula, Emily C L Wong, John K Marshall, et al.
Therapeutic Advances in Gastroenterology|January 15, 2024
Treatment persistence and switching patterns of ABP 501 in European patients with inflammatory bowel diseaseRan Jin, Silvia Kruppert, Florian Scholz, et al.
Journal of Crohn'S & Colitis|March 11, 2021
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc AnalysisNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|May 14, 2013
52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressantsWalter Reinisch, William J Sandborn, Remo Panaccione, et al.
Clinical Therapeutics|January 27, 2020
Population Pharmacokinetics and Exposure-Response Modeling of Golimumab in Adults With Moderately to Severely Active Ulcerative ColitisOmoniyi J Adedokun, Zhenhua Xu, Sam Liao, et al.
Journal of Crohn'S & Colitis|September 15, 2020
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI TrialsNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Pageof 36

Showing results (91-100 of 352) with videos related to

Sort By:
Pageof 36
World Journal of Gastroenterology|November 28, 2018
Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic reviewJulian Panes, Walter Reinisch, Ewa Rupniewska, et al.
Gut|November 7, 2022
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trialHeinz Zoller, Myles Wolf, Irina Blumenstein, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates|October 2, 2018
A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient GroupsJeremy Yongwen Ng, Usha Chauhan, David Armstrong, et al.
Crohn'S & Colitis 360|February 13, 2023
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative AnalysisDavid T Rubin, Laurent Peyrin-Biroulet, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2021
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative ColitisNeeraj Narula, Emily C L Wong, John K Marshall, et al.
Therapeutic Advances in Gastroenterology|January 15, 2024
Treatment persistence and switching patterns of ABP 501 in European patients with inflammatory bowel diseaseRan Jin, Silvia Kruppert, Florian Scholz, et al.
Journal of Crohn'S & Colitis|March 11, 2021
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc AnalysisNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|May 14, 2013
52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressantsWalter Reinisch, William J Sandborn, Remo Panaccione, et al.
Clinical Therapeutics|January 27, 2020
Population Pharmacokinetics and Exposure-Response Modeling of Golimumab in Adults With Moderately to Severely Active Ulcerative ColitisOmoniyi J Adedokun, Zhenhua Xu, Sam Liao, et al.
Journal of Crohn'S & Colitis|September 15, 2020
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI TrialsNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Pageof 36